QGel SA Company Profile, Contacts & Intelligence

QGel SA Overview

QGel was a biomedical technology company specialized in organoid applications and solutions. QGel technology was acquired by a Precision Cancer Technologies Inc. (PCT) in 2021. The company raised CHF 25 million to develop the QGel technology consisting of a portfolio of 5 international patent families. QGel's hydrogel technology mimics the microenvironment surrounding cells inside the human body. This feature facilitates growing patient cells from biopsies in a lab without losing the unique biological characteristics of the patient. With patient samples grown in a lab, many potential anti-cancer therapies can be tested on patient cancer avatars, ex vivo, to observe how each tumor clone responds to each therapy option, giving oncologists insight to expected patient response.

Headquarters

Lausanne, Vaud, Ch

Website

www.pct.bio

Industry

Biotechnology Research

Founded

2009

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

QGel SA Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

QGel SA People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to QGel SA

Explore companies in related markets and compare their industry and employee estimates.